Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure CC transcript Appointed director Inv. presentation Appointed CFO
|
PDL BIOPHARMA, INC. (PDLI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/07/2020 |
4/A
| Imbrogno Edward (VP Finance, CAO and Acting CFO) has filed a Form 4 on PDL BIOPHARMA, INC.
Txns:
| Granted 292,208 shares
@ $0 |
|
04/07/2020 |
4/A
| Monnet Dominique (President and CEO) has filed a Form 4 on PDL BIOPHARMA, INC.
Txns:
| Granted 1,233,766 shares
@ $0 |
|
04/07/2020 |
4/A
| Jene Jill M. (VP, Business Development) has filed a Form 4 on PDL BIOPHARMA, INC.
Txns:
| Granted 194,805 shares
@ $0 |
|
04/07/2020 |
4/A
| Stone Christopher Lewis (VP, Gen. Counsel & Secretary) has filed a Form 4 on PDL BIOPHARMA, INC.
Txns:
| Granted 422,078 shares
@ $0 |
|
04/16/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
04/16/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
04/16/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
04/16/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
01/28/2016 |
4/A
| Stone Christopher Lewis (VP, Gen. Counsel & Secretary) has filed a Form 4 on PDL BIOPHARMA, INC. |
04/17/2009 |
4/A
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on PDL BIOPHARMA, INC. |
04/13/2009 |
4/A
| SANDMAN PAUL W (Director) has filed a Form 4 on PDL BIOPHARMA, INC. |
|
|